The Froedtert & MCW health network has been using the Xealth digital health platform, which is integrated into its EHR system ...

The CUSIP number for the Company's common stock will remain unchanged.

Specifically, SL dosing of ‘1104 resulted in reduced inflammatory cell infiltration, including eosinophils and neutrophils, comparable to SQ and IV routes. SL dosing of ‘1104 also led to a reduction ...

In the supplementary post-hoc analysis, treatment with solengepras 150 mg group reduced OFF time by -1.78 hours (p= 0.0045) compared to placebo and increased good ON time by +1.3 hours (p=0.04).

ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will ...

Anne Breum, one of the employee-elected members of the Board of Directors of Novozymes A/S, part of Novonesis Group (the “Company”), has decided to step down as a board member. The first alternate, ...

Iris Bincovich, CEO of Innocan Pharma, will be presenting at 2PM ET at the Lotus Suite West on October 30th. Members of the Innocan Pharma management will also be holding one-on-one investor meetings ...

The Ensign Group, Inc. (Nasdaq: ENSG or the “Company”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, ...

PharmAla and CCrest Labs have terminated their supply agreement. CCrest was contracted in 2022 to distribute PharmAla’s MDMA to doctors under the Special Access Program. PharmAla will rely on other ...

Icovamenib is an oral covalent menin inhibitor in clinical development to investigate its impact on the function of insulin-producing beta cells ...

En 2023, le Centre d’excellence en oncologie a traité 25 % de l’ensemble des cas de cancer déclarés en Arabie saoudite, ...

RIYADH, Saudi Arabia, Oct. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues ...